The Fund aims to provide a high and increasing monthly income together with long term capital growth by investing primarily in shares of UK companies and sterling denominated fixed interest securities.
Name | % Net Assets |
---|---|
Vodafone Group | 5.9% |
GlaxoSmithKline | 5.9% |
Royal Dutch Shell | 5.6% |
Try 5% 03/2012 | 5.4% |
TRY 5.75% 12/09 | 4.4% |
BP | 4.2% |
Rio Tinto | 3.6% |
HSBC Hldgs | 3.6% |
AstraZeneca | 3.2% |
Try 8% 12/15 | 2.6% |
Key | % Net Assets |
---|---|
Vodafone Group | 5.9% |
GlaxoSmithKline | 5.9% |
Royal Dutch Shell | 5.6% |
Try 5% 03/2012 | 5.4% |
Other | 77.2% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 11/02/1989 |
---|---|
Fund Manager | Tim Rees |
TER | - |
Minimum Investment | |
---|---|
Initial | 500000 |
Additional | n/a |
Savings | 100 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.65% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.03 |
You are here: research